Host factors in the pathogenesis of HIV disease

被引:146
作者
Cohen, OJ
Kinter, A
Fauci, AS
机构
[1] Natl. Inst. Allerg. and Infect. Dis., Laboratory of Immunoregulation, Bethesda, MD
[2] Natl. Inst. Allerg. and Infect. Dis., Laboratory of Immunoregulation, MSC 1876, Bethesda, MD 20892-1876
关键词
D O I
10.1111/j.1600-065X.1997.tb01005.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Host factors play an important role in determining rates of disease progression in human immunodeficiency virus (HIV)-infected individuals. HIV is able to subvert the host immune system by infecting CD4(+) T cells that normally orchestrate immune responses and by inducing the secretion of proinflammatory cytokines that the virus can utilize to its own replicative advantage. The recognition that certain chemokine receptors serve as necessary co-factors for MV entry into its target cells as well as the fact that ligands for these receptors can modulate the efficiency of HN infection has expanded the number and scope of host factors that may impact the pathogenesis of HIV disease. This area of investigation will no doubt yield novel therapeutic strategies for intervention in HIV disease; however, caution is warranted in light of the enormous complexity of the pleiotropic cytokine and chemokine networks and the uncertainty inherent in manipulating these systems. HIV-infected long-term non-progressors represent an excellent model to study potential host factors involved in HN disease pathogenesis. Genetic factors certainly have a major impact on the immune responses mounted by the host. In this regard, a polymorphism in the gene for the HIV co-receptor CC chemokine receptor 5 (CCR5), which serves as a coreceptor for macrophage (M)-tropic strains of HIV, affords a high degree of protection against HIV infection in individuals homozygous for the genetic defect and some degree of protection against disease progression in HIV-infected heterozygotes. HIV-specific immune responses, including cytotoxic T-lymphocyte (CTL) responses and neutralizing antibody responses, also appear to play salutary roles in protecting against disease progression.
引用
收藏
页码:31 / 48
页数:18
相关论文
共 264 条
  • [1] CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1
    Alkhatib, G
    Combadiere, C
    Broder, CC
    Feng, Y
    Kennedy, PE
    Murphy, PM
    Berger, EA
    [J]. SCIENCE, 1996, 272 (5270) : 1955 - 1958
  • [2] Cytokine patterns in adults with AIDS
    Alonso, K
    Pontiggia, P
    Medenica, R
    Rizzo, S
    [J]. IMMUNOLOGICAL INVESTIGATIONS, 1997, 26 (03) : 341 - 350
  • [3] HIV coreceptor downregulation as antiviral principle: SDF-1 alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication
    Amara, A
    LeGall, S
    Schwartz, O
    Salamero, J
    Montes, M
    Loetscher, P
    Baggiolini, M
    Virelizier, JL
    ArenzanaSeisdedos, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) : 139 - 146
  • [4] Antinori A, 1992, Allergol Immunopathol (Madr), V20, P249
  • [5] SERUM TUMOR-NECROSIS-FACTOR-ALPHA, INTERLEUKIN 1-BETA, P24 ANTIGEN CONCENTRATIONS AND CD4+ CELLS AT VARIOUS STAGES OF HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION IN CHILDREN
    ARDITI, M
    KABAT, W
    YOGEV, R
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (06) : 450 - 455
  • [6] ARENDRUP M, 1992, J ACQ IMMUN DEF SYND, V5, P303
  • [7] Human chemokines: An update
    Baggiolini, M
    Dewald, B
    Moser, B
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 675 - 705
  • [8] HIV SUPPRESSION BY INTERLEUKIN-16
    BAIER, M
    WERNER, A
    BANNERT, N
    METZNER, K
    KURTH, R
    [J]. NATURE, 1995, 378 (6557) : 563 - 563
  • [9] Comparable biological and molecular determinants in HIV type 1-infected long-term nonprogressors and recently infected individuals
    Balotta, C
    Bagnarelli, P
    Riva, C
    Valenza, A
    Antinori, S
    Colombo, MC
    Sampaolesi, R
    Violin, M
    DePasquale, MP
    Moroni, M
    Clementi, M
    Galli, M
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (04) : 337 - 341
  • [10] Differential effects of interleukin-12, interleukin-15, and interleukin-2 on human immunodeficiency virus type 1 replication in vitro
    BayardMcNeeley, M
    Doo, H
    He, SH
    Hafner, A
    Johnson, WD
    Ho, JL
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1996, 3 (05) : 547 - 553